GALECTIN THERAPEUTICS INC Contracts & Agreements

Form of Warrant (Filed With SEC on July 26, 2022)

Line of Credit Letter Agreement, dated as of July 25, 2022, by and between Richard E. Uihlein and the Company (Filed With SEC on July 26, 2022)

Form of Convertible Promissory Note (Filed With SEC on July 26, 2022)

Employment Amendment (Filed With SEC on July 26, 2022)

2023 Deferred Stock Unit Agreement (Filed With SEC on July 26, 2022)

2020 Deferred Stock Unit Amendment (Filed With SEC on July 26, 2022)

Unsecured Convertible Promissory Note, dated December 20, 2021 (Filed With SEC on December 21, 2021)

Loan Agreement, dated September 17, 2021 (Filed With SEC on September 21, 2021)

Unsecured Convertible Promissory Note, dated September 17, 2021 (Filed With SEC on September 21, 2021)

Convertible Promissory Note, dated April 16, 2021 (Filed With SEC on April 19, 2021)

Description of Registrants securities (Filed With SEC on March 31, 2021)

Employment Agreement, dated August 31, 2020, between Galectin Therapeutics Inc. and Joel Lewis (Filed With SEC on September 2, 2020)

Deferred Stock Unit Agreement, dated August 31, 2020, between Galectin Therapeutics Inc. and Joel Lewis (Filed With SEC on September 2, 2020)

Retirement Agreement, dated August 31, 2020, between Galectin Therapeutics Inc. and Harold Shlevin (Filed With SEC on September 2, 2020)

Consulting Agreement, dated August 31, 2020, between Galectin Therapeutics Inc. and Harold Shlevin (Filed With SEC on September 2, 2020)

Work Order, dated as of June 22, 2020, by and between Galectin Therapeutics Inc. and Covance Inc (Filed With SEC on June 26, 2020)

Master Services Agreement, effective as of March 12, 2020, by and between Galectin Therapeutics, Inc. and Covance Inc (Filed With SEC on March 17, 2020)

Work Order, dated as of March 12, 2020, by and between Galectin Therapeutics, Inc. and Covance Clinical Research Unit Inc (Filed With SEC on March 17, 2020)

Employment Agreement, dated February 19, 2020, between Galectin Therapeutics Inc. and Pol F. Boudes, M.D (Filed With SEC on February 20, 2020)

Galectin Therapeutics 2009 Incentive Compensation Plan (as amended) (Filed With SEC on March 6, 2019)

Second Amendment to Common Stock Purchase Warrant, dated January 11, 2019, by and between Richard E. Uihlein and the Company (Filed With SEC on January 15, 2019)

Form of Amended and Restated Class B Common Stock Purchase Warrant (Filed With SEC on January 15, 2019)

Form of Amended and Restated 10X Fund Class B Common Stock Purchase Warrant (Filed With SEC on January 15, 2019)

Second Amendment to Line of Credit Letter Agreement, dated January 11, 2019, by and between Richard E. Uihlein and the Company (Filed With SEC on January 15, 2019)

First Amendment to Common Stock Purchase Warrant, dated December 20, 2018, by and between Richard E. Uihlein and the Company (Filed With SEC on January 3, 2019)

First Amendment to Line of Credit Agreement, dated as of December 20, 2018, by and between Richard E. Uihlein and the Company (Filed With SEC on January 3, 2019)

First Amendment to Employment Agreement (Filed With SEC on June 12, 2018)

Form of Common Stock Purchase Warrant (Filed With SEC on December 19, 2017)

Line of Credit Agreement, dated as of December 19, 2017, by and between Richard E. Uihlein and the Company (Filed With SEC on December 19, 2017)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2017)

GALECTIN THERAPEUTICS INC. Common Stock (par value $0.001per share) At Market Issuance Sales Agreement (Filed With SEC on May 19, 2017)

GALECTIN THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on December 29, 2016)

GALECTIN THERAPEUTICS, INC. SUBSCRIPTION AGREEMENT (Filed With SEC on December 29, 2016)

SECOND AMENDMENT TOSECURITIES PURCHASE AGREEMENT (Filed With SEC on December 29, 2016)

GALECTIN THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT CLASS B-3 (Filed With SEC on September 27, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 27, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 27, 2016)

LOCK-UP LETTER AGREEMENT September 22, 2016 (Filed With SEC on September 27, 2016)

EXHIBIT A (Filed With SEC on June 20, 2016)

GALECTIN THERAPEUTICS INC. EMPLOYMENT AGREEMENT (Filed With SEC on May 10, 2016)

PROJECT ADDENDUM MODIFICATION (Filed With SEC on March 15, 2016)

COMMON STOCK PURCHASE WARRANT GALECTIN THERAPEUTICS, INC. (Filed With SEC on November 20, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 20, 2015)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on November 20, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 20, 2015)

PROJECT ADDENDUM (Filed With SEC on March 12, 2015)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 12, 2014)

GALECTIN THERAPEUTICS INC. Common Stock (par value $0.001per share) At Market Issuance Sales Agreement (Filed With SEC on October 25, 2013)

GALECTIN THERAPEUTICS INC. COMMON STOCK PURCHASE WARRANT CLASS A-2 (Filed With SEC on August 14, 2013)

GALECTIN THERAPEUTICS INC. COMMON STOCK PURCHASE WARRANT CLASS B (Filed With SEC on August 14, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2013)

AMENDMENT TO INDEPENDENT CONSULTING AGREEMENT (Filed With SEC on August 14, 2013)

STOCK OPTION AGREEMENT GALECTIN THERAPEUTICS INC. STOCK OPTION AGREEMENT FOR THOMAS MCGAULEY AGREEMENT (Filed With SEC on August 14, 2013)

AMENDED AND RESTATED MASTER SERVICES AGREEMENT (Filed With SEC on May 10, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2012)

INDEPENDENT CONSULTING AGREEMENT (Filed With SEC on September 21, 2012)

GALECTIN THERAPEUTICS, INC. AMENDED EMPLOYMENT AGREEMENT July 1, 2012 (Filed With SEC on July 25, 2012)

7 Wells Avenue, Suite 34 Newton, MA 02459 O: 617 ###-###-#### F: 617 ###-###-#### CONSULTING AGREEMENT (Filed With SEC on May 1, 2012)

GALECTIN THERAPEUTICS INC. INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA (Filed With SEC on March 30, 2012)

$10,435,005 of Units GALECTIN THERAPEUTICS INC. Units Consisting of Two Shares of Common Stock and One Warrant to Purchase One Share of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 23, 2012)

GALECTIN THERAPEUTICS INC. FORM OF WARRANT AGREEMENT (Filed With SEC on March 23, 2012)

GALECTIN THERAPEUTICS INC. CONSULTING AGREEMENT MARCH 2, 2012 (Filed With SEC on March 5, 2012)

COLLABORATION, SUPPLY, MARKETING AND DISTRIBUTION AGREEMENT (Filed With SEC on December 20, 2011)

COLLABORATION, SUPPLY, MARKETING AND DISTRIBUTION AGREEMENT (Filed With SEC on November 10, 2011)

GALECTIN THERAPEUTICS INC. EMPLOYMENT AGREEMENT (Filed With SEC on July 5, 2011)

GALECTIN THERAPEUTICS INC. EMPLOYMENT AGREEMENT (Filed With SEC on June 2, 2011)

MASTER SERVICES AGREEMENT (Filed With SEC on April 28, 2011)

PRO-PHARMACEUTICALS, INC. AMENDED EMPLOYMENT AGREEMENT (Filed With SEC on April 6, 2011)

SEPARATION AGREEMENT (Filed With SEC on April 6, 2011)

PRO-PHARMACEUTICALS, INC. AMENDED EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2011)

PRO-PHARMACEUTICALS, INC. NON-QUALIFIED STOCK OPTION AGREEMENT FOR PETER G. TRABER, M.D. (Filed With SEC on March 9, 2011)

PRO-PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT CLASS A-1 (Filed With SEC on January 27, 2011)

PRO-PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT CLASS A-2 (Filed With SEC on January 27, 2011)

PRO-PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT CLASS B-1 (Filed With SEC on January 27, 2011)

AGREEMENT (Filed With SEC on January 27, 2011)

Pro-Pharmaceuticals, Inc. SUBSCRIPTION AND SUITABILITY AGREEMENT (Filed With SEC on January 6, 2011)

DAVANAT® BINDING TERM SHEET PRO-PHARMACEUTICALS INC (PRO-PHARMACEUTICALS) & PROCAPS S.A. (PROCAPS) EXCLUSIVE SUPPLY & DISTRIBUTION AGREEMENT FORDAVANAT® (Filed With SEC on May 12, 2010)

10X FUND, L.P. 1099 Forest Lake Terrace Niceville, Florida 32578 February 11, 2010 (Filed With SEC on February 17, 2010)

10X FUND, L.P. 1099 Forest Lake Terrace (Filed With SEC on August 14, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on May 28, 2009)

PRO-PHARMACEUTICALS, INC. RESTRICTED STOCK AGREEMENT (Filed With SEC on March 30, 2009)

PRO-PHARMACEUTICALS, INC. NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on March 30, 2009)

PRO-PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on March 30, 2009)

PRO-PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT CLASS A-1 (Filed With SEC on February 18, 2009)

PRO-PHARMACEUTICALS, INC. (Filed With SEC on February 18, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 18, 2009)

PROMISSORY NOTE (Filed With SEC on February 18, 2009)

SECURITY AGREEMENT (Filed With SEC on February 18, 2009)

ESCROW AGREEMENT (Filed With SEC on February 18, 2009)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 18, 2009)

TECHNOLOGY TRANSFER AND SHARING AGREEMENT (Filed With SEC on February 18, 2009)

CONSULTING AGREEMENT (Filed With SEC on February 18, 2009)

SEPARATION AGREEMENT (Filed With SEC on February 18, 2009)

PRO-PHARMACEUTICALS, INC. 2009 INCENTIVE COMPENSATION PLAN PRO-PHARMACEUTICALS, INC. 2009 INCENTIVE COMPENSATION PLAN (Filed With SEC on February 18, 2009)

FORM OF PRO-PHARMACEUTICALS, INC. DEALER-MANAGER AGREEMENT ___________, 2009 (Filed With SEC on February 2, 2009)

THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE COMPANYS PROSPECTUS DATED FEBRUARY , 2009 (THE PROSPECTUS) AND ARE INCORPORATED HEREIN BY REFERENCE. COPIES OF... (Filed With SEC on February 2, 2009)

[FORM OF NOTICE TO STOCKHOLDERS] PRO-PHARMACEUTICALS, INC. (Filed With SEC on February 2, 2009)

[FORM OF NOTICE TO STOCKHOLDERS ACTING AS NOMINEES] PRO-PHARMACEUTICALS, INC. (Filed With SEC on February 2, 2009)

[FORM OF NOTICE TO BENEFICIAL STOCKHOLDERS OF COMMON STOCK] PRO-PHARMACEUTICALS, INC. NOTICE TO CLIENTS OF STOCKHOLDERS WHO ARE ACTING AS NOMINEES Up to [ ] Shares of Common Stock... (Filed With SEC on February 2, 2009)

FORM OF BENEFICIAL OWNER ELECTION (Filed With SEC on February 2, 2009)

PRO-PHARMACEUTICALS, INC. FORM OF DEALER-MANAGER WARRANT [ ] shares of Common Stock _____________________,2009 (Filed With SEC on February 2, 2009)

FORM OF SUBSCRIPTION AGENT AGREEMENT (Filed With SEC on February 2, 2009)

LICENSE AGREEMENT (Filed With SEC on February 2, 2009)

Pro-Pharmaceuticals, Inc. INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA (Filed With SEC on November 19, 2008)

THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE COMPANYS PROSPECTUS DATED , 2008 (THE PROSPECTUS) AND AREINCORPORATED HEREIN BY REFERENCE. COPIES OF THE... (Filed With SEC on November 19, 2008)

[FORM OF NOTICE TO STOCKHOLDERS] PRO-PHARMACEUTICALS, INC. (Filed With SEC on November 19, 2008)

[FORM OF NOTICE TO STOCKHOLDERS ACTING AS NOMINEES] PRO-PHARMACEUTICALS, INC. (Filed With SEC on November 19, 2008)

[FORM OF NOTICE TO BENEFICIAL STOCKHOLDERS OF COMMON STOCK] PRO-PHARMACEUTICALS, INC. NOTICE TO CLIENTS OF STOCKHOLDERS WHO ARE ACTING AS NOMINEES Up to [ ] Shares of Common Stock... (Filed With SEC on November 19, 2008)

FORM OF BENEFICIAL OWNER ELECTION (Filed With SEC on November 19, 2008)

FORM OF SUBSCRIPTION AGENT AGREEMENT (Filed With SEC on November 19, 2008)

Members NASD & SIPC 405 Lexington Ave. * New York, NY 10174 * Tel ###-###-#### * (800) 724-0761 * fax ###-###-#### * www.maximgrp.com New York, NY * Long Island, NY * Chicago, IL... (Filed With SEC on February 15, 2008)

[LONG TERM] [SHORT TERM] COMMON STOCK PURCHASE WARRANT PRO-PHARMACEUTICALS,INC. (Filed With SEC on February 15, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 15, 2008)

SUBJECT TO LEGAL REVIEW AND COMMITMENT COMMITTEE APPROVAL (Filed With SEC on February 15, 2008)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 26, 2007)

PRO-PHARMACEUTICALS, INC. (Filed With SEC on December 21, 2007)

Name: (Filed With SEC on October 9, 2007)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 9, 2007)

PRO-PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on October 9, 2007)

EMPLOYMENT AGREEMENT (Filed With SEC on September 27, 2007)

COMMON STOCK PURCHASE WARRANT PRO-PHARMACEUTICALS, INC. (Filed With SEC on June 20, 2007)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 20, 2007)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 20, 2007)

WAIVER AND EXCHANGE AGREEMENT (Filed With SEC on March 21, 2007)

OFFICE LEASE AGREEMENT BETWEEN NS 7/57 ACQUISITION LLC, a Delaware limited liability company (LANDLORD) AND PRO-PHARMACEUTICALS,INC., a Nevada corporation (TENANT) TABLE OF... (Filed With SEC on May 5, 2006)

DUEFEBRUARY , 2008 (Filed With SEC on February 15, 2006)

COMMONSTOCK PURCHASE WARRANT To Purchase Shares of Common Stock of (Filed With SEC on February 15, 2006)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 15, 2006)

Summary of 2005 Employee Incentive Compensation Plan (Filed With SEC on November 10, 2005)

PRO-PHARMACEUTICALS, INC. (Filed With SEC on February 11, 2005)

PRO-PHARMACEUTICALS, INC. (Filed With SEC on November 19, 2004)

OPTION AGREEMENT (Filed With SEC on November 19, 2004)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 16, 2004)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 16, 2004)

COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of Pro-Pharmaceuticals, Inc. (Filed With SEC on August 16, 2004)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 9, 2004)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 9, 2004)

COMMON STOCK PURCHASE WARRANT To Purchase Shares ofCommon Stock of Pro-Pharmaceuticals, Inc. (Filed With SEC on April 9, 2004)

Pro-Pharmaceuticals, Inc. (Filed With SEC on March 30, 2004)

PRO-PHARMACEUTICALS, INC. (Filed With SEC on March 30, 2004)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 10, 2003)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 10, 2003)

COMMONSTOCK PURCHASE WARRANT To Purchase Shares of Common Stock of (Filed With SEC on October 10, 2003)

COMMONSTOCK PURCHASE WARRANT To Purchase 65,729 Shares of CommonStock of Pro-Pharmaceuticals, Inc. (Filed With SEC on October 10, 2003)

Category

Industry

Companies

Contracts

GALECTIN THERAPEUTICS INC Contracts & Agreements